Amid reports of waning COVID-19 immunity, the Food and Drug Administration (FDA) is expected to officially approve a third dose of messengerRNA vaccines for the general public. Moderna and Pfizer are mRNA vaccines. The FDA has already approved a third COVID-19 vaccine dose for those who have compromised immune systems, as part of their primary vaccine series. That third vaccine is not considered…